Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our
treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
Stem Cell Research Study Shows Adult Stem Cells Improve Diabetes Type 2
Dr. Roberto Fernandez Vina is scheduled to present a stem cell research study in which he helped improve Diabetes Type 2 patients with their own Adult Stem Cells and followed up on them for 3 years! The stem cell treatment and therapy was a great success. The results are below.
Stem Cell Pioneer and Doctor to Present Adult Stem Cell Study At ISCT Meeting
Dr. Fernandez Vina will present the following abstract at the International Society for Cellular Therapy (ISCT) in San Diego in July 2009. This is another milestone in Adult Stem Cell research as Dr. Fernandez-Vina has probably been the world's foremost stem cell doctor in helping patients with their own stem cells.
FIRST REPORT FROM Dr. VINA OF FIRST THREE YEARS FOLLOW UP OF AUTOLOGOUS STEM CELLS IMPLANT IN DIABETES TYPE 2
Objectives: To evaluate the long time performance of Stem cells implant in pancreas in Diabetes Type 2 patients The adults stem cells CD34(+)CD38(-) have demonstrated the capacity to differentiate into functional cells in the endocrine pancreas.
Method: After three years on cell therapy for diabetes,patients the conclusions are optimistic. In this study were observed the evolution of 58 patients Diabetic type 2, 37 male, 21 female, 29- 71 years old. 29 patients were under insulin therapy, and 20 patients using Sulphonylureas + Biguanides. For the transplantation, we harvested bone marrow from the iliac crest by aspiration. The sample was processed using a density gradient separation method, obtaining 120ml (±95) of CD34(+)CD38(-) solution. For the implant was procedure a catheterization through Splenic Artery. No complications or further events were observed during or after the procedure. The patients were subjected to clinical and blood samples control during the 36 months following the implant.
Type 2 Patients
|
Before Implant
|
6 Months
|
36 Months
|
Results %
|
P values
|
C-Peptide Basal (ng/ml)
|
1.18
|
1.76
|
2.19
|
48.52%
|
P=0.036
|
C-Peptide after meal (ng/ml)
|
2.22
|
2.95
|
4.40
|
95.52%
|
HgbA1c
|
9.14
|
8.25
|
6.35
|
21.95%
|
P=0.003
|
Insulin Basal (MU/ml)
|
12.33
|
15.27
|
15.02
|
25.26%
|
P=0.016
|
Insulin After Meal (MU/ml)
|
19.11
|
26.23
|
34.7
|
58.75 %
|
Pills per day
|
2.25
|
1.55
|
0.33
|
44.36%
|
P=0.0007
|
Insulin Dosis (IU/day)
|
50.59
|
14.55
|
9.55
|
89.03%
|
P= 0.037
|
Conclusions: the implant of mononuclear CD34+CD38- ( stem cells) from autologous bone marrow improve pancreatic function in patients with type 2 diabetes, in a safe form and is maintained after 3 years at least
Stem Cell Treatment Now Available, But Not In the United States
Dr. Fernandez Vina from Argentina now is treating patients with their own stem cells in El Salvador (a short flight from Houston) for conditions such as Spinal Cord Injury, Heart Disease, Lung Diseases (COPD and Emphysema) Diabetes Type 1 and Diabetes Type 2 as well as many other conditions.
If you are further interested in this Adult Stem Cell treatment, please go to our Repair Stem Cell Institute website and fill out this
stem cell treatment request form and we will assist you in receiving more stem cell therapy information regarding Dr. Fernandez Vina